Hamid Khoja, Chief Scientific Officer at FibroBiologics, Inc. (FBLG), bought 30,000 shares at $0.38 ($11K) on 2026-03-04, disclosed to the SEC on 2026-03-05.
Open-market purchase of $11k FBLG by Chief Scientific Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |